IP Library Granted Patent US 12,339,201
Granted Patent B2
US 12,339,201 · App. 17/299,171 · Granted Jun 24, 2025

Gas sensor module

Inventors: Jaron Acker (Madison, WI); Peter James Clark (Hazelwood, MO); Cedric Assambo (Hazelwood, MO); Michael McAtamney (Hazelwood, MO); John Klaus (Cottage Grove, WI); Robin Roehl (Hazelwood, MO)
Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
G01N1/24A61M16/04A61M16/085A61M16/1005G01N33/0009A61M2016/1025A61M2205/3327A61M2205/3368
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,339,201
App. No.
17/299,171
Granted
Jun 24, 2025
Kind
B2
Abstract

A removable gas sensor module is provided for a therapeutic gas delivery device. The gas sensor module includes a sample chamber which receives a sample gas from the therapeutic gas delivery device. A gas detection unit includes a plurality of sensors operable to measure at least one property of the sample gas. The sensors include two or more of a gas detection sensor, a humidity sensor, a temperature sensor, or a combination thereof. The gas sensor module is self-contained within the therapeutic gas delivery device and swappable with another gas sensor module.

Claims (44)

1. A removable gas sensor module for a therapeutic gas delivery device, the gas sensor module comprising:

a sample chamber operable to receive a sample gas from the therapeutic gas delivery device; and

a gas detection unit comprising a plurality of sensors operable to measure at least one property of the sample gas, wherein the plurality of sensors include two or more of a gas detection sensor, a humidity sensor, a temperature sensor, or a combination thereof,

wherein the gas sensor module is self-contained within the therapeutic gas delivery device and swappable with another gas sensor module,

wherein the plurality of sensors is pre-calibrated and shelf stable in a non-installed configuration for at least 1 month,

wherein the plurality of sensors includes an NO sensor and an NO 2 sensor,

wherein the plurality of sensors is operable to receive an electrical potential from a voltage source when the gas sensor module is not installed in the therapeutic gas delivery device, and

wherein the electrical potential maintains the pre-calibration of the plurality of sensors when the gas sensor module is not installed in the therapeutic gas delivery device.

2. The gas sensor module of claim 1 , wherein replacement of the gas sensor module results in less than 5 minutes of down time of the measurement of at least one property of the sample gas.

3. The gas sensor module of claim 1 , wherein replacement of the gas sensor module results in no down time in delivery of therapeutic gas from the therapeutic gas delivery device.

4. The gas sensor module of claim 1 , wherein the gas detection sensor is one or more of an NO sensor, an NO 2 sensor, an O 2 sensor, or combinations thereof.

5. The gas sensor module of claim 1 , wherein the gas detection unit comprises at least two gas detection sensors.

6. The gas sensor module of claim 1 , wherein the gas detection unit comprises two or more different sensors.

7. The gas sensor module of claim 6 , wherein the gas detection unit comprises one or more gas detection sensors and a humidity sensor.

8. The gas sensor module of claim 1 , wherein the at least one property of the sample gas is one or more of a concentration of NO, a concentration of NO 2 , a concentration of O 2 , humidity, temperature, or a combination thereof.

9. The gas sensor module of claim 1 further comprising a sensing circuit operable to detect and report the at least one property of the sample gas to a gas analyzer controller in the therapeutic gas delivery device.

10. The gas sensor module of claim 1 , wherein the therapeutic gas delivery device is continuously operable when the gas sensor module is replaced.

11. The gas sensor module of claim 1 , wherein the sample chamber comprises an inner housing and an outer housing.

12. The gas sensor module of claim 1 , wherein the gas detection unit is operable to electronically store or send to the therapeutic gas delivery device serial numbers, calibration data, and/or usage information of the gas sensor module.

13. The gas sensor module of claim 1 , wherein the gas sensor module is shelf stable for at least 3 months.

14. A gas sensor assembly comprising:

the gas sensor module of claim 1 ;

an assembly inner housing operable to removably receive the gas sensor module; and

a gas analyzer unit comprising:

a sample tube fluidly connected to the gas delivery device and the gas sensor module operable to receive the sample gas; and

a pump connected to the gas sensor module through the sample tube, wherein the pump is operable to pump the sample gas through the gas sensor module.

15. The gas sensor assembly of claim 14 , wherein the gas analyzer unit further comprises a gas analyzer controller.

16. The gas sensor assembly of claim 14 , wherein the gas analyzer unit further comprises an assembly main housing operable to receive the assembly inner housing, wherein the assembly main housing is within the therapeutic gas delivery device.

17. The gas sensor assembly of claim 14 , wherein at least a portion of the sample tube is a Nafion tube.

18. An apparatus comprising:

a voltage source; and

a gas sensor module comprising:

a sample chamber operable to receive a sample gas from a therapeutic gas delivery device; and

a gas detection unit comprising a plurality of sensors operable to measure at least one property of the sample gas, wherein the plurality of sensors include two or more of a gas detection sensor, a humidity sensor, a temperature sensor, or a combination thereof,

wherein the gas sensor module is self-contained within the therapeutic gas delivery device and swappable with another gas sensor module,

wherein the plurality of sensors is pre-calibrated and stable in a non-installed configuration for at least 1 month,

wherein the plurality of sensors includes an NO sensor and an NO 2 sensor,

wherein the voltage source provides an electrical potential across the plurality of sensors in the gas detection unit to maintain the pre-calibration of the plurality of sensors when the gas sensor module is in the non-installed configuration.

19. The apparatus of claim 18 , wherein the voltage source is a battery or a power transformer.

20. The apparatus of claim 18 , wherein the voltage source ceases to provide the electrical potential across the plurality of sensors when the gas sensor module is installed within the therapeutic gas delivery device.

21. The apparatus of claim 18 , wherein the voltage source is internal to the gas sensor module.

22. A method for providing a gas sensor module comprising:

calibrating the plurality of sensors in the gas sensor module of claim 1 ; and

providing electrical potential across the plurality of sensors to maintain the calibration of the plurality of sensors.

Assignments (13)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 73375 FRAME 395. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 72331 FRAME 1. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
CHANGE OF NAME Recorded Jun 8, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 056523/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056473/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: ACKER, JARON; CLARK, PETER JAMES; ASSAMBO, CEDRIC; MCATAMNEY, MICHAEL; KLAUS, JOHN; ROEHL, ROBIN
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 056473/0223 →